Mesa Laboratories (MLAB) Common Equity (2011 - 2026)

Mesa Laboratories has disclosed Common Equity across 16 years of filings, most recently posting $188.8 million for Q2 2026.

• In Q2 2026, Common Equity rose 9.43% year-over-year to $188.8 million; the TTM figure through Jun 2026 stood at $188.8 million (up 9.43% YoY), while the FY2026 annual figure was $186.2 million, up 16.53% from the prior year.
• Common Equity came in at $188.8 million for Q2 2026 at Mesa Laboratories, up from $186.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $403.0 million in Q4 2023 to a low of $145.4 million in Q1 2024.
• Average Common Equity over 5 years is $266.3 million, with a median of $187.7 million recorded in 2025.
• Year-over-year, Common Equity tumbled 63.05% in 2024 and increased 20.28% in 2025.
• Over 5 years, Common Equity stood at $387.2 million in 2022, then increased by 4.07% to $403.0 million in 2023, then slumped by 61.48% to $155.2 million in 2024, then increased by 20.28% to $186.7 million in 2025, then gained by 1.11% to $188.8 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $188.8 million in Q2 2026, $186.2 million in Q1 2026, and $186.7 million in Q4 2025.